Cargando…

Emerging strategies in BRCA-positive pancreatic cancer

PURPOSE: We propose a treatment algorithm for PDAC with particular emphasis on BRCA1 or 2 mutation-positive patients. Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest diseases in the United States and Europe. BRCA1 and BRCA2 are among the most common of the known genetic mutations inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowalewski, Adam, Szylberg, Łukasz, Saganek, Michał, Napiontek, Wojciech, Antosik, Paulina, Grzanka, Dariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Review – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061050/ https://www.ncbi.nlm.nih.gov/pubmed/29777302 http://dx.doi.org/10.1007/s00432-018-2666-9

Ejemplares similares

Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma
por: Kowalewski, Adam, et al.
Publicado: (2018)

Detection of BRAF V600E Mutation in Ganglioglioma and Pilocytic Astrocytoma by Immunohistochemistry and Real-Time PCR-Based Idylla Test
por: Durślewicz, Justyna, et al.
Publicado: (2020)

Targeting the Deterministic Evolutionary Trajectories of Clear Cell Renal Cell Carcinoma
por: Kowalewski, Adam, et al.
Publicado: (2020)

TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma
por: Kowalewski, Adam, et al.
Publicado: (2022)

Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm
por: Kowalewski, Adam, et al.
Publicado: (2020)

Expression differences between proteins responsible for DNA damage repair according to the Gleason grade as a new heterogeneity marker in prostate cancer
por: Jaworski, Damian, et al.
Publicado: (2019)

Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review
por: Janiczek, Marlena, et al.
Publicado: (2017)

Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy
por: Strasenburg, Wiktoria, et al.
Publicado: (2022)

The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer
por: Gzil, Arkadiusz, et al.
Publicado: (2020)

Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options
por: Janiczek, Marlena, et al.
Publicado: (2020)

Prognostic Significance of TLR2, SMAD3 and Localization-dependent SATB1 in Stage I and II Non–Small-Cell Lung Cancer Patients
por: Durślewicz, Justyna, et al.
Publicado: (2021)

Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma
por: Klimaszewska-Wiśniewska, Anna, et al.
Publicado: (2021)

Low Expression of MATR3 Is Associated with Poor Survival in Clear Cell Renal Cell Carcinoma
por: Durślewicz, Justyna, et al.
Publicado: (2023)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
por: Hatano, Yuichiro, et al.
Publicado: (2020)

Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers
por: Sadłecki, Paweł, et al.
Publicado: (2019)

Cellular and molecular alterations induced by low-dose fisetin in human chronic myeloid leukemia cells
por: Klimaszewska-Wiśniewska, Anna, et al.
Publicado: (2019)

Plasma protein changes reflect colorectal cancer development and associated inflammation
por: Urbiola-Salvador, Víctor, et al.
Publicado: (2023)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
por: Ferreyra, Yomali, et al.
Publicado: (2023)

Short Term Pre-Operative Oral Corticosteroids—Tissue Remodeling in Chronic Rhinosinusitis with Nasal Polyps
por: Radajewski, Kamil, et al.
Publicado: (2021)

Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers
por: Hamdi, Yosr, et al.
Publicado: (2021)

Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer
por: Buchholz, Karolina, et al.
Publicado: (2021)

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors
por: O’Sullivan, Ciara C., et al.
Publicado: (2014)

High expression of RUVBL1 and HNRNPU is associated with poor overall survival in stage I and II non-small cell lung cancer patients
por: Durślewicz, Justyna, et al.
Publicado: (2022)

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
por: Golan, T, et al.
Publicado: (2014)

Genomic Profiling Comparison of Germline BRCA and Non-BRCA Carriers Reveals CCNE1 Amplification as a Risk Factor for Non-BRCA Carriers in Patients With Triple-Negative Breast Cancer
por: Huang, Xin, et al.
Publicado: (2020)

HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters
por: Smolińska, Marta, et al.
Publicado: (2019)

Editorial: Targeting Pancreatic Cancer: Strategies and Hopes
por: Manu, Kanjoormana Aryan, et al.
Publicado: (2022)

Next-generation sequencing based detection of BRCA1 and BRCA2 large genomic rearrangements in Chinese cancer patients
por: Hua, Dingchao, et al.
Publicado: (2022)

The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma—Recent Findings and Review
por: Borowczak, Jędrzej, et al.
Publicado: (2022)

The Prognostic Role of CDK9 in Bladder Cancer
por: Borowczak, Jędrzej, et al.
Publicado: (2022)

Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer
por: Du, Juan, et al.
Publicado: (2022)

Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations
por: Pouptsis, Athanasios, et al.
Publicado: (2020)

Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects
por: Peixoto, Ana, et al.
Publicado: (2020)

BRCA and Early Events in the Development of Serous Ovarian Cancer
por: George, Sophia H. L., et al.
Publicado: (2014)

Genomic Profile and BRCA-1 Promoter Methylation Status in BRCA Mutated Ovarian Cancer: New Insights in Predictive Biomarkers of Olaparib Response
por: Franzese, Elisena, et al.
Publicado: (2019)

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
por: Fanale, Daniele, et al.
Publicado: (2021)

BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
por: Solano, Angela R., et al.
Publicado: (2018)

Complete Pathological Response to Platinum-Based Neoadjuvant Chemotherapy in BRCA2-Associated Locally Advanced Pancreatic Cancer: A Case Report and Literature Review
por: Asiri, Mohamed S, et al.
Publicado: (2023)

Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer
por: Henderson, Emily A., et al.
Publicado: (2023)

GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers
por: Lesueur, Fabienne, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ojnnsm1upu0g2jccc5d94qesh4